RecruitingNCT07790406

Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer


Sponsor

European Institute of Oncology

Enrollment

50 participants

Start Date

Feb 2, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called da Vinci Single Port for people with lung cancer (nsclc). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREda Vinci Single Port

U-RATS lobectomy


Locations(1)

Istituto Europeo di Oncologia

Milan, Mi, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07790406


Related Trials